Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00362284 · ClinicalTrials.gov registry record · NA
Comprehensive Support for Alzheimer's Disease Caregivers
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
NCT00362284: Completed NA study, sponsored by University of Minnesota.
NCT00362284 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 161 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00362284, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of a comprehensive counseling and support intervention for people who care for parents with Alzheimer's disease (AD) or other dementias on outcomes such as stress, depression and ability to postpone or avoid nursing home placement.
Primary Outcome
Adult child caregivers self-reported whether the care recipient was admitted to a residential care setting and the date of admission.
Interventions
- BEHAVIORAL NYUCI-AC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2005-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT00362284 record still lists
NCT00362284 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which NYUCI-AC is the first listed.
NCT00362284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00362284 about?
NCT00362284 is a clinical study titled "Comprehensive Support for Alzheimer's Disease Caregivers". The purpose of this study is to determine the effectiveness of a comprehensive counseling and support intervention for people who care for parents with Alzheimer's disease (AD) or other dementias on outcomes such as stress, depression and ability to postpone or avoid nursing home placement.
What is the current status of trial NCT00362284?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2005-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00362284?
The interventions under investigation include: NYUCI-AC (BEHAVIORAL).
Who is sponsoring clinical trial NCT00362284?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00362284's enrollment target sits among peer trials
161 628th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia